Results 241 to 250 of about 651,988 (307)
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr +5 more
wiley +1 more source
Editorial: Sarcoidosis diagnosis and treatment based on etiology. [PDF]
Sawahata M, Eishi Y.
europepmc +1 more source
Objective The purpose was to evaluate a biomarker score consisting of MUC5B rs35705950 promoter variant, plasma matrix metalloproteinase‐7 (MMP‐7), and serum anti–malondialdehyde‐acetaldehyde (anti‐MAA) antibody for rheumatoid arthritis (RA)–associated interstitial lung disease (ILD) risk stratification.
Kelsey Coziahr +16 more
wiley +1 more source
Advancing clinical utility of artificial intelligence: lessons from developing a model to predict cochlear implant eligibility. [PDF]
Carducci V +5 more
europepmc +1 more source
Objective We investigated whether a diagnosis of rheumatoid arthritis (RA) affects the quality of inpatient acute myocardial infarction (AMI) care and long‐term mortality post‐AMI. Methods We analyzed data from 784,091 adults, 6,047 with a diagnosis of RA, from England and Wales hospitalized with AMI between 2005 and 2019 from the Myocardial Ischaemia ...
Megan Butler +8 more
wiley +1 more source
Why study design matters: evaluating bias and generalizability in contrast-enhanced mammography research. [PDF]
Lobbes MBI, Nelemans PJ.
europepmc +1 more source
Objective We developed a novel electronic health record sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient‐facing graphical interface designed for use during outpatient visits (“RA PRO dashboard”).
Gabriela Schmajuk +16 more
wiley +1 more source
A complete blood count-based machine learning model for rapid differentiation of aplastic anemia, immune thrombocytopenia, and myelodysplastic syndromes in routine clinical practice. [PDF]
Wang X, Huang J, Xi J, Liu H, Yuan Y.
europepmc +1 more source
Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers. [PDF]
Collinson, P
core +1 more source

